3507-49-1

Basic information

• Product Name: 2-BROMO-7-NITROBENZOTHIAZOLE
• Synonyms: 2-BROMO-7-NITROBENZOTHIAZOLE;2-BroMo-7-nitrobenzo[d]thiazole
• CAS NO: 3507-49-1
• Molecular Formula: C₇H₃BrN₂O₂S
• Molecular Weight: 259.08
• Mol File: 3507-49-1.mol

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 2-BROMO-7-NITROBENZOTHIAZOLE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-BROMO-7-NITROBENZOTHIAZOLE(3507-49-1)
• EPA Substance Registry System: 2-BROMO-7-NITROBENZOTHIAZOLE(3507-49-1)

Safety Data

• Hazardous Substances Data: 3507-49-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical and Agrochemical Industries:
2-BROMO-7-NITROBENZOTHIAZOLE is utilized as a building block in the synthesis of pharmaceuticals and agrochemicals. Its specific molecular structure allows it to be a key component in the development of new drugs and pesticides, enhancing their efficacy and targeting specific biological pathways.
Used in Organic Synthesis:
As a reagent in organic synthesis, 2-BROMO-7-NITROBENZOTHIAZOLE is employed for the introduction of the 2-bromo-7-nitrobenzothiazole moiety into various molecules. This can improve the properties of the resulting compounds, such as their stability, reactivity, or biological activity.
Used in Antimicrobial Applications:
2-BROMO-7-NITROBENZOTHIAZOLE has demonstrated antimicrobial properties and is being studied for its potential use as an antimicrobial agent. This could be particularly valuable in the development of new treatments for infections caused by drug-resistant bacteria.
Safety Considerations:
It is important to handle 2-BROMO-7-NITROBENZOTHIAZOLE with care, as it is considered harmful if swallowed, inhaled, or comes into contact with the skin. Proper safety measures should be taken during its use to minimize potential health risks.

Upstream product

• 89793-81-7 7-nitrobenzo[d]thiazol-2-amine 

Downstream Products

• 851886-49-2 2-(2,4-dimethylphenoxy)-7-nitro-1,3-benzothiazole 

Relevant articles and documents

NITROGEN-CONTAINING FUSED HETEROCYCLIC COMPOUNDS

There is provided a CRF receptor antagonist comprising a compound of the formula (I): wherein, ring A is a 5-membered ring represented by the formula (A'): wherein X is a carbon and X is an oxygen, a sulfur or - NR -,or formula (A"): wherein X is a nitrogen and R is an optionally substituted hydrocarbyl, Ris an amino substituted by two optionally substituted hydrocarbyl groups, Ris an phenyl, Y is CR or a nitrogen, Y is CRor a nitrogen and Yis CRor a nitrogen, provided that one or less of Y, Y, and Y is nitrogen, W is a bond, -(CH2)n-, and Z is a bond, -NR -,etc.; or a salt thereof or a prodrug thereof.